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Objectives Our aim was to examine the relationship of arterial stiffness to measures of atherosclerosis, arterial calcifica-
tion, and bone mineral density (BMD); the heritability of these measures; and the degree to which they are ex-
plained by common genetic influences.
Background Arterial stiffening relates to arterial calcification, but this association could result from coexistent atherosclero-
sis. A reciprocal relationship between arterial stiffening/calcification and BMD could explain the association be-
tween cardiovascular morbidity and osteoporosis.
Methods We examined, in 900 women from the Twins UK cohort, the relationship of carotid-femoral pulse wave velocity
(cfPWV) to measures of atherosclerosis (carotid intima-media thickening; carotid/femoral plaque), calcification
(calcified plaque [CP]; aortic calcification by computed tomography, performed in subsample of 40 age-matched
women with low and high cfPWV), and BMD.
Results The cfPWV independently correlated with CP but not with intima-media thickness or noncalcified plaque. Total
aortic calcium, determined by computed tomography, was significantly greater in subjects with high cfPWV (me-
dian Agatston score 450.4 compared with 63.2 arbitrary units in subjects with low cfPWV, p  0.001). There
was no independent association between cfPWV and BMD. Adjusted heritability estimates of cfPWV and CP
were 0.38 (95% confidence interval: 0.19 to 0.59) and 0.61 (95% confidence interval: 0.04 to 0.83), respec-
tively. Shared genetic factors accounted for 92% of the observed correlation (0.38) between cfPWV and CP.
Conclusions These results suggest that the association between increased arterial stiffness and the propensity of the arterial
wall to calcify is explained by a common genetic etiology and is independent of noncalcified atheromatous
plaque and independent of BMD. (J Am Coll Cardiol 2011;57:1480–6) © 2011 by the American College of Car-
diology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.09.079Stiffening of large elastic arteries is a hallmark of vascular
aging strongly predictive of cardiovascular disease (CVD)
related events such as myocardial infarction and stroke (1).
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accepted September 20, 2010.Animal models and observations in humans suggest that
arterial calcification might be an important determinant of
arterial stiffness (2–4). It has been suggested that vascular
calcification might occur in parallel with demineralization of
bone, with a reciprocal relationship between arterial stiffen-
ing and osteoporosis explaining the epidemiological associ-
ation of osteoporosis with CVD events (5–8). However,
whether the association of arterial stiffening with arterial
calcification merely reflects the presence of atherosclerosis is
unknown (9), and the relation of arterial stiffness to bone
mineral density (BMD) has not been clearly established.
The object of the present study was to examine the
relationship of arterial stiffness to measures of atherosclero-
sis, arterial calcification, and BMD in women of middle age
from the Twins UK cohort. We examined the heritability of
these characteristics and the degree to which they could be
explained by common genetic influences.
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Subjects. Subjects were female Caucasian twins (n  900,
396 monozygotic [MZ] and 504 dizygotic [DZ]) from the
Twins UK cohort, a cohort with characteristics similar to the
general U.K. population (10). All women underwent assess-
ment of arterial stiffness by measurement of carotid-femoral
pulse wave velocity (cfPWV), carotid/femoral ultrasound, and
BMD. A subsample of 40 age-matched women selected from
the first (low cfPWV) and third tertile (high cfPWV) of the
cfPWV distribution underwent computed tomography (CT)
of the aorta. The study was approved by St. Thomas’ Hospital
Research Ethics Committee, and written informed consent
was obtained from all subjects.
Biochemistry. Fasting serum total cholesterol, high-
density lipoprotein cholesterol, triglycerides, glucose, cal-
cium, and phosphate were measured in an accredited labo-
ratory. Low-density lipoprotein cholesterol was estimated
with the Friedewald equation. In the CT substudy, serum
25 (OH) vitamin D; C-terminal telopeptides of type 1
collagen, as a marker of bone resorption; and bone-specific
alkaline phosphatase and osteocalcin, as a marker of bone
formation, were measured by chemiluminescence and by
enzyme-linked immunosorbent assays (IDS, Boldon,
United Kingdom).
Blood pressure and pulse wave velocity (PWV). Mea-
surements were performed in a quiet temperature-
controlled vascular laboratory (22°C to 24°C). Brachial
blood pressure was measured in duplicate, with a validated
oscillometric device (Omron 705CP, Omron, Tokyo, Ja-
pan) after subjects had been seated for at least 10 min.
The cfPWV was obtained with subjects supine with the
SphygmoCor system (Atcor Medical, Sydney, Australia).
The path distance between the carotid and femoral sites was
estimated from the distance between the sternal notch and
femoral artery at the point of applanation.
Carotid intima-media thickness (IMT) and carotid/
femoral plaque. The left and right carotid and femoral
arteries were visualized with B-mode ultrasound (Siemens
CV70, Siemens, Erlangen, Germany, with 13-MHz vascu-
lar probe). Common carotid IMT was measured in the near
and far walls, 1 to 2 cm proximal to the carotid bifurcation
with automated wall tracking software (Medical Imaging
Applications, Coralville, Iowa) during diastole in an area
free of overt plaque. Mean values of IMT in the near and far
walls of both arteries were used for analysis. Arterial walls
were examined for plaque in the common carotids, carotid
bifurcations, origins of the internal and external carotid
arteries, common femoral arteries, femoral bifurcations, and
the origins of the superficial and deep femoral arteries.
Plaque was defined in the longitudinal view as focal widen-
ing and protrusion into the lumen of 1.5-mm thickness
relative to neighboring areas and confirmed in transverse
view. Plaque was graded according to echogenicity into
predominately echolucent/noncalcified (50% of similar
echogenicity to blood) or echogenic/calcified (50% of osimilar echogenicity to the bright
echo of the media–adventitia inter-
face) (11,12). Measurements were
made by 2 experienced observers
(B.J. and M.C.) unaware of clini-
cal data of the study participants at
the time of measurement.
BMD. The BMD was deter-
mined at the lumbar spine (L1
to L2) and hip with dual X-ray
absorption (Hologic Discovery,
Hologic, Bedford, Massachu-
setts). Quality control scans were
performed daily with a spine
phantom.
CT. Non–contrast-enhanced CT
was performed with a 16-slice
CT helical scanner (Brilliance
CT component of the Philips
Precedence SPECT/CT system,
Philips, Eindhoven, the Nether-
lands). Three-millimeter trans-
verse nonoverlapping slices be-
tween the carotid and aortic
bifurcation were acquired (16 
1.5 mm collimation, 120 kVp, 55
mAs/slice, 0.5-s gantry rotation time) and viewed offline
with a Hermes workstation. A modification of the Agatston
score was used to quantify aortic calcium: each cross-
sectional slice was analyzed separately, and calcification was
defined as any area 1 mm2 with attenuation 130
ounsfield units. The Agatston score (13) for each such
rea was determined by multiplying lesion area (total num-
er of pixels) by a weighting factor (of 1, 2, 3, and 4 for
aximum attenuations of 130 to 199, 200 to 299, 300 to
99, and400 Hounsfield units, respectively). Calcium was
urther quantified in cubic millimeters with the volume
core calculated as the product of voxel volume and number
f voxels in the region of interest. For both methods, the
otal calcium score was obtained by summing the score in
ach cross-sectional slice.
tatistical analysis. Data analysis was performed with SPSS
version 16.0, SPSS, Inc., Chicago, Illinois) and STATA
oftware (version 6, Stata Corporation, College Station,
exas). Subject characteristics are presented as mean  SD
nless otherwise stated. Comparisons between groups were
ade with Student t test, Wilcoxon signed rank test,
hi-square test, and analysis of variance (Bonferroni test was
sed for post hoc comparison). Univariate regression anal-
sis was first used to examine the relationships of vascular
easures to age, mean arterial pressure (MAP), heart rate,
ody mass index, total cholesterol, high-density lipoprotein
holesterol, low-density lipoprotein cholesterol, triglycer-
des, glucose, current smoking, and menopausal status and
reatment for blood pressure, cholesterol, diabetes, and
Abbreviations
and Acronyms
ACE  additive genetic
component (a2), common
(c2), and unique (e2
incorporating measurement
error) environment
components
BMD  bone mineral
density
cfPWV  carotid-femoral
pulse wave velocity
CI  confidence interval
CP  calcified plaque
CT  computed
tomography
CVD  cardiovascular
disease
DZ  dizygotic twins
IMT  intima-media
thickness
MAP  mean arterial
pressure
MZ  monozygotic twins
PWV  pulse wave velocitysteoporosis. Forward stepwise multivariable regression
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Arterial Calcification and Stiffness March 29, 2011:1480–6analysis including all variables significantly associated on
univariate analysis was then performed to examine indepen-
dent associations. Correlation of observations between twin
pairs was adjusted for with a cluster mean or, in multiple
regression analysis, a cluster variable (14). All statistical tests
were done at the 5% level of significance.
Heritability analysis. Heritability analysis was performed
ith the classic twin model (15). Intraclass correlation
oefficients were compared for MZ and DZ twins to
xamine twin resemblance. Variance of each phenotype was
ssumed to derive from an additive genetic component (a2),
common (c2), and unique (e2; incorporating measurement
rror) environment components (ACE model). Structural
quation modeling was used to estimate parameters of the
CE model and corresponding confidence intervals (CIs)
ith the method of maximum likelihood (Mx software,
niversity of Virginia). Significance of each parameter was
etermined by likelihood ratio tests. Significantly skewed
ariables were log transformed for analysis. Heritability of
ategorical variables was estimated with a liability-threshold
odel. Thresholds and the tetrachoric correlation were
stimated with the method of maximum likelihood. Vari-
nce decomposition of the correlation in liability was ap-
lied to an ACE model. For age adjustment, the liability
hreshold was assumed to be linearly related to age (16). A
ommon genetic basis for the association between arterial
haracteristics was explored by examining cross-trait, cross-
win correlations in a bivariate model (17). The phenotypic
orrelation (rph) between cfPWV (categorized into 3 groups
ivided at the 75th and 90th percentiles) and calcified
laque (CP) was partitioned into that explained by additive
enetic factors (ra), shared environment (rc), and nonshared
environment (re).
esults
ubject characteristics. Characteristics of women in the
otal cohort are shown in Table 1. The MZ and DZ twins
ere comparable for age, blood pressure, and cfPWV.
here were small but statistically significant differences in
moking, antihypertensive treatment, low-density lipopro-
ein cholesterol, and glucose between MZ and DZ twins
Table 1). Of the subjects, 41% had plaque present at 1 or
ore of the arterial sites. Of these, 32% were classified as
cholucent (noncalcified) plaques, and 68% were classified
s echogenic (calcified) plaques.
elation of cfPWV to risk factors, IMT, and carotid/
emoral plaque. In univariate analysis, cfPWV was associ-
ted with most traditional risk factors, including age, blood
ressure, low-density lipoprotein-cholesterol, triglycerides,
nd fasting glucose. However, in multivariable analysis,
fPWV was significantly, independently, positively corre-
ated only with age, blood pressure, heart rate, and fasting
lucose (each p  0.0001) (Table 2). The cfPWV was not
ndependently correlated to carotid IMT when this was
dded to a multivariable model (including age, MAP, heart sate, glucose, or a model including all variables significantly
orrelated with cfPWV on univariate analysis). There was
lso no independent correlation between cfPWV and IMT
hen subjects taking antihypertensive treatment were ex-
luded. Similarly, cfPWV was not independently correlated
ith the presence of noncalcified plaque. However, cfPWV
as significantly correlated with the presence of CP (p 
.01, adjusting for all confounders, including hormone
eplacement therapy and menopausal status) (Table 2).
resence of CP remained significantly associated with PWV
fter adjustment for twin family structure (p  0.05). The
fPWV was significantly higher in subjects with CP versus
hose with no plaque (mean 9.69  1.9 m/s vs. 8.54  1.4
m/s, respectively, p  0.01, and those with noncalcified
plaque, 9.08  1.7 m/s, p  0.01). The difference in PWV
emained significant between individuals with no plaque
nd CP after adjustment for age, MAP, heart rate, fasting
lucose, hormone replacement therapy use, and menopausal
tatus.
T. Women that underwent a CT scan had characteristics
imilar to those in the main study, and there were no
ignificant differences in age, MAP, heart rate, fasting
lucose, or bone chemistry between women selected from
he first and third tertiles of the distribution of cfPWV in
he main study (Table 3). The mean PWV for subjects
Characteristics of MZ and DZTwins in the Total CohortTable 1 Characteristics of MZ and DZTwins in the Total Cohort
MZ (n  396) DZ (n  504)
Age (yrs) 57.7 10.0 58.0 8.0
Height (cm) 161.4 6.0 161.9 6.0
Weight (kg) 69 13 69.7 13.0
Current smokers 27 (7) 60 (12)*
Post-menopausal 247 (62) 316 (63)
Diabetes 6 (2) 3 (1)
Systolic blood pressure (mm Hg) 127.4 17.0 128.6 15.0
Diastolic blood pressure (mm Hg) 78.2 10.0 78.9 9.0
Heart rate (beats/min) 63.5 9.0 63.2 9.0
Total cholesterol (mmol/l) 5.71 1.1 5.57 0.9
HDL cholesterol (mmol/l) 1.77 0.5 1.82 0.5
LDL cholesterol (mmol/l) 3.42 1.0 3.24 0.9†
Triglycerides (mmol/l) 1.14 0.6 1.12 0.6
Glucose (mmol/l) 5.15 0.6 5.05 0.6
Hypertension treatment 94 (24) 81 (16)†
Lipid-lowering treatment 51 (13) 65 (13)
HRT treatment 22 (6) 37 (7)
cfPWV (m/s) 8.98 1.8 8.89 1.6
CIMT (mm) 0.66 0.66
Plaque 150 (38) 217 (43)
Echolucent 46 (12) 71 (14)
Echogenic 104 (26) 146 (29)
BMD (hip, g/cm2) 0.91 (0.13) 0.91 (0.12)
BMD (lumbar spine, g/cm2) 0.98 (0.14) 0.96 (0.14)
Data are mean  SD or n (%). Compared with monozygotic (MZ) twins, *p  0.01; †p  0.05.
BMD  bone mineral density; cfPWV  carotid-femoral pulse wave velocity; CIMT  common
arotid intima-media thickness; DZ  dizygotic; HDL  high-density lipoprotein; HRT  hormone
eplacement therapy; LDL  low-density lipoprotein.elected from the first tertile was similar to that for the
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March 29, 2011:1480–6 Arterial Calcification and Stiffnessoriginal cohort tertile (7.5  1.1 m/s vs. 7.4  0.6 m/s),
hereas that for the third tertile was slightly less than the
riginal cohort tertile (10.1  1 m/s vs. 10.8  1.3 m/s).
ortic calcification (1 mm2 in 1 or more slices of the
orta) was present in 63% of subjects. Aortic calcium score
as significantly greater in subjects with high cfPWV
within the third tertile in the main study) compared with
ge-matched subjects with low (first tertile) cfPWV (p 
.001 for both Agatston and Volume score) (Table 3). On
ultivariate regression analysis across the whole group—
djusting for age, MAP, heart rate, glucose, and menopausal
tatus—PWV was independently correlated with aortic
alcification (beta  0.49, p  0.001, and beta  0.42, p 
.01, for Agatston and volume score, respectively). Results
ere similar when adjusted for twin–twin correlations.
elationship of BMD to cfPWV, IMT, and carotid/
emoral plaque. BMD was negatively correlated with age
r  0.31 and r  0.24 at the hip and lumbar spine,
espectively p  0.0001), but despite the correlation of
fPWV with age (r  0.49, p  0.0001), cfPWV did not
orrelate with BMD at the hip (or lumbar spine) either on
nivariate analysis or multivariable analysis (data not
hown). There was also no significant independent correla-
ion between BMD (at hip or lumbar spine) and carotid/
emoral plaque (either noncalcified or calcified plaque).
here was a weak but significant positive correlation be-
ween BMD and carotid IMT (beta  0.09, p  0.05, and
eta  0.13, p  0.01, for hip and spine, respectively) that
emained significant after adjustment for twin–twin corre-
ations and when subjects taking antihypertensive treatment
ere excluded.
eritability. The intraclass correlation coefficients for
MD (hip and spine), cfPWV, and CP were higher in MZ
ompared with DZ twin pairs (r  0.91 and r  0.55; r 
.87 and r  0.57; r  0.86 and r  0.56; and r  0.80 and
 0.59, respectively), suggesting a genetic influence on
hese traits. The fully adjusted ACE model confirmed an
dditive genetic component or heritability (h2) accounting
or 82% (95% CI: 0.69 to 0.85) and 77% (95% CI: 0.64 to
.82) of the variance of BMD at the hip and spine,
Multiple Regression Model:Relation of cfPWV to Risk Factors ande sures of Atherosclerosis/Calcification
Table 2
Multiple gre sion Model:
Relation of cfPWV to Risk Factors and
Measures of Atherosclerosis/Calcification
Variable Beta R2 Change p Value
Age 0.37 0.23 0.0001
MAP 0.34 0.14 0.0001
Heart rate 0.17 0.03 0.0001
Glucose 0.10 0.01 0.0001
CIMT — — NS
Carotid/femoral plaque (y/n) — — NS
Calcified plaque (y/n) 0.08 0.01 0.01
n  900. Variables that did not enter the model include: smoking status, total cholesterol, LDL
holesterol, HDL cholesterol, triglycerides, menopausal status, HRT, blood pressure treatment, and
holesterol treatment.
MAP  mean arterial pressure; other abbreviations as in Table 1.espectively, and 38% (95% CI: 0.19 to 0.59) of the variancen cfPWV. Heritability of all plaque was only 5% (95% CI:
.00 to 0.61), but that of CP was 61% (95% CI: 0.04 to
.83), although the CIs for this categorical measure were
ider than those for the continuous measures. The within-
win correlation (rph) between cfPWV and CP was 0.39.
ross-twin, cross-trait correlations were higher in MZ
rPWV/CP  0.37) compared with DZ (rPWV/CP  0.29)
wins, suggesting that an additive genetic influence contrib-
tes to the observed correlation between cfPWV and CP.
he bivariate model that provided the best fit to the
bserved data was the AE model (Fig. 1), with 92% of the
henotypic correlation between cfPWV and CP explained
y additive genetic effects.
iscussion
rterial stiffness, as measured by cfPWV, is one of the
ost important predictors of future CVD events (1) but
hows little or no relation to conventional risk factors
ther than age and blood pressure (18). Furthermore,
nimal models of atherosclerosis suggest that arterial
tiffness is not affected by early atherosclerosis (19).
esults of the present study confirm the close association
f cfPWV with age and MAP and lack of or weak
ssociation with other risk factors such as smoking, lipid
ractions, and fasting glucose consistent with previous
tudies (18). We also examined the relation of cfPWV to
ubclinical measures of atherosclerosis: carotid IMT and
resence of atheromatous plaque in the carotid and
emoral arteries. Carotid IMT is one of the earliest
anifestations of subclinical atherosclerosis (20), al-
hough it might also be an adaptive response to increased
lood pressure (21). The presence of plaque might be
egarded as a more advanced manifestation of nonob-
Subject Characteristics, Bone Chemistry,and Aortic C l ifica on in CT SubstudyTable 3 Subject Charact ristics, Bone Chemistry,and Aortic Calcification in CT Substudy
Variable
Low cfPWV
(n  20)
High cfPWV
(n  20)
PWV (m/s) 7.5 1.2 10.1 1.0*
Age (yrs) 60 6.7 61.5 8.8
Height (cm) 163.6 7.7 164.3 4.9
Weight (kg) 66.6 6.1 70.2 12.0
MAP (mm Hg) 92.7 8.8 94.8 9.2
HR (beats/min) 61.2 8.0 71.5 16.0†
Fasting glucose (mmol/l) 5.13 0.51 5.05 0.64
Vitamin D (ng/ml) 19.2 8.0 23.9 10.0
Calcium (mmol/l) 2.4 0.1 2.4 0.1
Phosphate (mmol/l) 1.2 0.1 1.2 0.2
CTX (ng/ml) 0.44 0.2 0.46 0.2
Osteocalcin (ng/ml) 17.7 6.8 15.4 6.0
BAP (g/l) 14.9 6.2 13.4 4.4
Agatston score (AU) 63.2 (483) 450.4 (3,518)‡
Volume score (cm3) 0.05 (0.05) 0.38 (2.70)‡
Values are mean  SD or median (interquartile range). Compared with low cfPWV, *p  0.0001;
†p  0.05; ‡p  0.001.AU arbitrary units; BAP bone-specific alkaline phosphatase; CTX C-terminal telopeptide of
type 1 protein; HR  heart rate; other abbreviations as in Table 1.
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Arterial Calcification and Stiffness March 29, 2011:1480–6structive atherosclerosis. We found no independent as-
sociation of cfPWV with IMT or with the presence of
noncalcified atheroma. These observations suggest that
atherosclerotic change within the arterial wall is not
necessarily associated with arterial stiffening, in keeping
with animal models of atherosclerosis (19) and previous
human studies (22). Indeed, increased distensibility has
been noted at the site of atherosclerotic plaques in the
carotid artery (23).
An alternative explanation for arterial stiffening is that it
is associated with calcification within atherosclerotic plaque
(intimal calcification) and/or by medial calcification, which
might be caused by a process distinct from atherosclerosis.
However, the majority of previous studies have not at-
tempted to distinguish whether the association of arterial
stiffness with calcification is independent of atherosclerosis.
A major finding of the present study is that—despite lack of
correlation with risk factors for atherosclerosis, IMT, and
presence of noncalcified plaque—we observed a signifi-
cant association of cfPWV with CP detected by ultra-
sound in the carotid and femoral arteries and with total
Figure 1 Path Diagram of Bivariate Genetic Model for PWV and
Results for the ACE model are displayed in italic and for the AE model in bold ital
E  nonshared environment. Squares  observed variables; circles  latent variaaortic calcification measured by CT. These findings areconsistent with a previous study suggesting an association
of arterial stiffness with echogenic plaque in the carotid
artery (11).
The calcification detected in the present study by ultra-
sound was localized to atherosclerotic atheroma, whereas
that detected by CT could have been intimal and/or medial
(early medial calcification often being fragmented rather
than diffuse [24]). Thus our study does not distinguish
whether arterial calcification associated with arterial stiffen-
ing is primarily of the intimal or medial type. Lack of
association of cfPWV with risk factors for atherosclerosis,
with carotid IMT, and with carotid/femoral plaque suggests
that, if plaque calcification influences arterial stiffness di-
rectly, it is the propensity of plaque to calcify rather than the
amount of plaque that determines arterial stiffness. How-
ever, it is possible that degeneration of elastin (with an
associated increase in arterial stiffening) renders it more
susceptible to calcification (25). Calcification could thus
be secondary to early degenerative change in elastin and
act to amplify arterial stiffening initially caused by elastin
ified Plaque, Including Genetic and Environmental Correlations
th 95% confidence intervals). A  additive genetic; C  shared environment;
ingle-headed arrows  causal paths; and double-headed arrows  correlations.Calc
ics (wi
ble; sdegradation.
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March 29, 2011:1480–6 Arterial Calcification and StiffnessVascular calcification is now recognized to be an active
process regulated by molecular mechanisms that parallel
those of bone mineralization (5). Vascular calcification can
be induced by genetic manipulation of proteins regulating
bone resorption, producing reciprocal effects on bone den-
sity and vascular calcification (26). It has been suggested
that parallel processes of arterial calcification and bone
demineralization explain the association between CVD and
osteoporosis. Although several studies report an inverse
association between vascular calcification and BMD (27–29),
this finding is not universal (30–33), and vascular calcifica-
tion has been observed in conditions of low bone turnover
(34). Examining the relation between arterial stiffness and
BMD might be a more sensitive way of testing the hypoth-
esized reciprocal relationship between BMD and vascular
calcification/arterial stiffening, because arterial stiffness
could be influenced by minor degrees of calcification. Thus
far, such studies have been of modest sample size, used
different methodology to assess BMD and arterial stiffness,
and have yielded conflicting results (35–39). As far as we are
aware, this is the largest study to examine the relationship
between aortic stiffness as measured by cfPWV and BMD
determined with dual X-ray absorption. We found no
significant association between cfPWV and BMD, either in
univariate analysis or after accounting for possible con-
founders in multivariable analysis.
An alternative hypothesis linking osteoporosis to CVD
events is that atherosclerosis within arteries supplying skel-
etal sites affects regional bone metabolism (5). Again,
previous studies have yielded conflicting results (40,41). In
the present study, BMD was not associated with presence of
plaque and was weakly independently positively correlated
to IMT, a correlation opposite to that expected if athero-
sclerosis were to cause osteoporosis. It is notable that a
similar positive association was seen between BMD and
IMT in younger women in the San Antonio Family
Osteoporosis study (42). Therefore, results of the present
study do not support a clear or direct relationship between
osteoporosis and atherosclerosis or arterial stiffness.
Results of the heritability analysis in this study confirm
the high heritability of BMD and moderate heritability of
cfPWV. A novel finding is that the presence of CP was
estimated to be of heritability similar to cfPWV. Although
the confidence limits for the heritability estimate for CP
were wide, they do suggest that arterial calcification has an
important genetic component that might be distinct from
that for atherosclerosis. Furthermore, this study shows that
the phenotypic correlation between arterial stiffness and
arterial calcification can be attributed to a common genetic
influence. Lack of heritability of noncalcified plaque and
lack of correlation of this with cfPWV suggest that CP
probably develops de novo rather than as a progression of
noncalcified plaque (in which case some intermediate asso-
ciation with cfPWV and genetic factors would be expected).
Study limitations. The study is limited to female twins.owever, the Twins UK cohort is comparable to thegeneral population of women in the U.K. for disease and
lifestyle characteristics such as blood pressure, hypertensive
drug use, and tobacco consumption (10). Findings in men
might differ, and a recent study by Collins et al. (43)
suggests peripheral arterial disease and increased peripheral
arterial stiffness are associated with bone loss and fractures
in the hip. We were not able to ascertain, due to limitations
of current imaging modalities, the extent of medial calcifi-
cation and its association with arterial stiffness. Finally, the
cross-sectional nature of the study limits conclusions on
causality; prospective and interventional studies will be
required to define the role of arterial calcification in arterial
stiffening.
Conclusions
In women, arterial stiffness is independent of noncalcified
atheroma but relates to arterial calcification, and this asso-
ciation is due to a common genetic influence on calcification
and stiffness. BMD is not independently related to arterial
stiffness or to measures of atherosclerosis.
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